Automate Your Wheel Strategy on MCK
With Tiblio's Option Bot, you can configure your own wheel strategy including MCK - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MCK
- Rev/Share 3230.1786
- Book/Share -0.8036
- PB -90.0983
- Debt/Equity -6.6441
- CurrentRatio 0.8762
- ROIC 0.2402
- MktCap 117162746563.0
- FreeCF/Share 81.9481
- PFCF 11.6049
- PE 26.9465
- Debt/Assets 0.1024
- DivYield 0.0032
- ROE -2.4527
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 2
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | MCK | Barclays | -- | Overweight | -- | $960 | Dec. 9, 2025 |
| Resumed | MCK | Mizuho | -- | Neutral | -- | $630 | Dec. 4, 2024 |
| Downgrade | MCK | Robert W. Baird | Outperform | Neutral | $603 | $531 | Sept. 24, 2024 |
| Reiterated | MCK | Leerink Partners | -- | Outperform | $670 | $665 | Sept. 5, 2024 |
News
McKesson Corporation: Strong Q3 Earnings But Upside Exhausted
Published: February 24, 2026 by: Seeking Alpha
Sentiment: Positive
McKesson Corporation shares are now fairly valued after a 16% price increase, prompting a Hold rating. Strong Q3 results were driven by 11% revenue growth and a 37% surge in the Oncology & Multispeciality segment, aided by M&A. Management raised FY2026 guidance, with EPS now expected at $38.80–39.20 and revenue growth at 12–16%.
Read More
Wall Street Analysts Think McKesson (MCK) Is a Good Investment: Is It?
Published: February 24, 2026 by: Zacks Investment Research
Sentiment: Positive
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read More
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
MCK Q3 Earnings & Sales Top Estimates, 2026 View Up
Published: February 06, 2026 by: Zacks Investment Research
Sentiment: Positive
McKesson beats Q3 EPS and revenue estimates, raises fiscal 2026 guidance, and delivers broad-based growth led by oncology, specialty distribution and technology.
Read More
How McKesson Stock Surged 17% In A Day
Published: February 06, 2026 by: Forbes
Sentiment: Positive
McKesson (MCK), a prominent pharmaceutical wholesaler, experienced a stock increase of 17% during a high-volume trading session. The driver for this surge was a strong Q3 earnings report that surpassed expectations and, more importantly, a significant rise in the full-year 2026 adjusted EPS forecast.
Read More
Why McKesson (MCK) is a Top Growth Stock for the Long-Term
Published: February 06, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
McKesson (MCK) Is Considered a Good Investment by Brokers: Is That True?
Published: February 05, 2026 by: Zacks Investment Research
Sentiment: Positive
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read More
Should You Buy, Sell, or Hold McKesson Before Q3 Earnings?
Published: February 03, 2026 by: Zacks Investment Research
Sentiment: Neutral
MCK approaches third-quarter earnings with strong growth expectations, but limited visibility on margins and investments keeps the outlook cautious.
Read More
Unlocking Q3 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics
Published: January 30, 2026 by: Zacks Investment Research
Sentiment: Positive
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for McKesson (MCK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
Read More
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Published: January 26, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
4 Medical Supply Stocks Poised to Gain in a Prospering Industry
Published: January 22, 2026 by: Zacks Investment Research
Sentiment: Neutral
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and ALGN.
Read More
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
Published: January 21, 2026 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Read More
Are Investors Undervaluing McKesson (MCK) Right Now?
Published: January 16, 2026 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Published: January 09, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why McKesson (MCK) is a Strong Growth Stock
Published: January 08, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
Published: January 08, 2026 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
McKesson Builds Earnings Momentum on Specialty and Automation
Published: January 05, 2026 by: Zacks Investment Research
Sentiment: Positive
McKesson posts a strong fiscal second quarter, lifts full-year EPS outlook, and shows how specialty growth and automation are reshaping its earnings power.
Read More
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
Published: December 30, 2025 by: Zacks Investment Research
Sentiment: Neutral
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
Mckesson Corporation Announces Third Quarter Fiscal 2026 Earnings Release Date
Published: December 22, 2025 by: Business Wire
Sentiment: Neutral
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2026 financial results after market close on Wednesday, February 4, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson's Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services l.
Read More
Why McKesson (MCK) is a Top Growth Stock for the Long-Term
Published: December 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Is Trending Stock McKesson Corporation (MCK) a Buy Now?
Published: December 10, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
Why Is McKesson (MCK) Down 5.2% Since Last Earnings Report?
Published: December 05, 2025 by: Zacks Investment Research
Sentiment: Negative
McKesson (MCK) reported earnings 30 days ago. What's next for the stock?
Read More
Here's Why McKesson (MCK) is a Strong Growth Stock
Published: November 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
3 Reasons Growth Investors Will Love McKesson (MCK)
Published: November 24, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) could produce exceptional returns because of its solid growth attributes.
Read More
Is McKesson (MCK) a Buy as Wall Street Analysts Look Optimistic?
Published: November 24, 2025 by: Zacks Investment Research
Sentiment: Positive
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read More
Final Trades: Freeport-McMoRan, Cisco, Teradyne and McKesson Corp.
Published: November 19, 2025 by: CNBC Television
Sentiment: Neutral
The Investment Committee give you their top stocks to watch for the second half.
Read More
Here's Why McKesson (MCK) is a Strong Value Stock
Published: November 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Published: November 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Why McKesson (MCK) is a Top Growth Stock for the Long-Term
Published: November 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
About McKesson Corporation (MCK)
- IPO Date 1994-11-10
- Website https://www.mckesson.com
- Industry Medical - Distribution
- CEO Brian S. Tyler
- Employees 44000